Electrostimulated bone marrow human mesenchymal stem cells produce follistatin

References

• Kogure K, Zhang YQ, Kanzaki M, Omata W, Mine T, Kojima I. Intravenous administration of follistatin: delivery to the liver and effect on liver regeneration after partial hepatectomy. Hepatology 1996; 24: 361–6
   Google Scholar
• Ohnishi N, Miyata T, Ohnishi H, Yasuda H, Tamada K, Ueda N, et al. Activin A is an autocrine activator of rat pancreatic stellate cells: potential therapeutic role of follistatin for pancreatic fibrosis. Gut 2003; 52: 1487–93
   PubMed Web of Science ®Google Scholar
• Maeshima A, Zhang YQ, Nojima Y, Naruse T, Kojima I. Involvement of the activin-follistatin system in tubular regeneration after renal ischemia in rats. J Am Soc Nephrol 2001; 12: 1685–95
   PubMed Web of Science ®Google Scholar
• Aoki F, Kurabayashi M, Hasegawa Y, Kojima I. Attenuation of bleomycin-induced pulmonary fibrosis by follistatin. Am J Respir Crit Care Med 2005; 172: 713–20
   PubMed Web of Science ®Google Scholar
• Iezzi S, Di Padova M, Serra C, Caretti G, Simone C, Maklan E, et al. Deacetylase inhibitors increase muscle cell size by promoting myoblast recruitment and fusion through induction of follistatin. Dev Cell 2004; 6: 673–84
   PubMed Web of Science ®Google Scholar
• Harrison CA, Gray PC, Vale WW, Robertson DM. Antagonists of activin signaling: mechanisms and potential biological applications. Trends Endocrinol Metab 2005; 16: 73–8
   PubMed Web of Science ®Google Scholar
• Ueno N, Ling N, Ying SY, Esch F, Shimasaki S, Guillemin R. Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone. Proc Natl Acad Sci USA 1987; 84: 8282–6
   PubMed Web of Science ®Google Scholar
• Sugino K, Kurosawa N, Nakamura T, Takio K, Shimasaki S, Ling N, et al. Molecular heterogeneity of follistatin, an activin-binding protein. Higher affinity of the carboxyl-terminal truncated forms for heparan sulfate proteoglycans on the ovarian granulosa cell. J Biol Chem 1993; 268: 15579–87
   PubMed Web of Science ®Google Scholar
• Ying SY. Inhibins, activins and follistatins. J Steroid Biochem 1989; 33: 705–13
   PubMedGoogle Scholar
• Kogawa K, Nakamura T, Sugino K, Takio K, Titani K, Sugino H. Activin-binding protein is present in pituitary. Endocrinology 1991; 128: 1434–40
   Google Scholar
• Shiozaki M, Sakai R, Tabuchi M, Nakamura T, Sugino K, Sugino H, et al. Evidence for the participation of endogenous activin A/erythroid differentiation factor in the regulation of erythropoiesis. Proc Natl Acad Sci USA 1992; 89: 1553–6
   PubMedGoogle Scholar
• Asashima M, Nakano H, Uchiyama H, Sugino H, Nakamura T, Eto Y, et al. Presence of activin (erythroid differentiation factor) in unfertilized eggs and blastulae of Xenopus laevis. Proc Natl Acad Sci USA 1991; 88: 6511–4
   Google Scholar
• Nakamura T, Hasegawa Y, Sugino K, Kogawa K, Titani K, Sugino H. Follistatin inhibits activin-induced differentiation of rat follicular granulosa cells in vitro. Biochim Biophys Acta 1992; 1135: 103–9
   Google Scholar
• Xiao S, Findlay JK. Interactions between activin and follicle-stimulating hormone-suppressing protein and their mechanisms of action on cultured rat granulosa cells. Mol Cell Endocrinol 1991; 79: 99–107
   PubMed Web of Science ®Google Scholar
• Aoki F, Kojima I. Therapeutic potential of follistatin to promote tissue regeneration and prevent tissue fibrosis. Endocr J 2007; 54: 849–54
   Google Scholar
• Sharma M, Kambadur R, Matthews KG, Somers WG, Devlin GP, Conaglen JV, et al. Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct. J Cell Physiol 1999; 180: 1–9
   PubMed Web of Science ®Google Scholar
• Morissette MR, Cook SA, Foo S, McKoy G, Ashida N, Novikov M, et al. Myostatin regulates cardiomyocyte growth through modulation of Akt signaling. Circ Res 2006; 99: 15–24
   PubMed Web of Science ®Google Scholar
• Florholmen G, Halvorsen B, Beraki K, Lyberg T, Sagen EL, Aukrust P, et al. Activin A inhibits organization of sarcomeric proteins in cardiomyocytes induced by leukemia inhibitory factor. J Mol Cell Cardiol 2006; 41: 689–97
   PubMed Web of Science ®Google Scholar
• Yndestad A, Ueland T, Oie E, Florholmen G, Halvorsen B, Attramadal H, et al. Elevated levels of activin A in heart failure: potential role in myocardial remodeling. Circulation 2004; 109: 1379–85
   PubMed Web of Science ®Google Scholar
• van den Berg G, Somi S, Buffing AA, Moorman AF, van den Hoff MJ. Patterns of expression of the Follistatin and Follistatin-like1 genes during chicken heart development: a potential role in valvulogenesis and late heart muscle cell formation. Anat Rec (Hoboken) 2007; 290: 783–7
   PubMedGoogle Scholar
• Adams D, Larman B, Oxburgh L. Developmental expression of mouse Follistatin-like 1 (Fstl1): dynamic regulation during organogenesis of the kidney and lung. Gene Expr Patterns 2007; 7: 491–500
   Google Scholar
• Takehara-Kasamatsu Y, Tsuchida K, Nakatani M, Murakami T, Kurisaki A, Hashimoto O, et al. Characterization of follistatin-related gene as a negative regulatory factor for activin family members during mouse heart development. J Med Invest 2007; 54: 276–88
   Google Scholar
• Modlin M, Forstner C, Hofer C, Mayr W, Richter W, Carraro U, et al. Electrical stimulation of denervated muscles: first results of a clinical study. Artif Organs 2005; 29: 203–6
   PubMed Web of Science ®Google Scholar
• Kern H, Salmons S, Mayr W, Rossini K, Carraro U. Recovery of long-term denervated human muscles induced by electrical stimulation. Muscle Nerve 2005; 31: 98–101
   PubMed Web of Science ®Google Scholar
• Carraro U, Rossini K, Mayr W, Kern H. Muscle fiber regeneration in human permanent lower motoneuron denervation: relevance to safety and effectiveness of FES-training, which induces muscle recovery in SCI subjects. Artif Organs 2005; 29: 187–91
   PubMed Web of Science ®Google Scholar
• Kuramochi Y, Guo X, Sawyer DB, Lim CC. Rapid electrical stimulation induces early activation of kinase signal transduction pathways and apoptosis in adult rat ventricular myocytes. Exp Physiol 2006; 91: 773–80
   PubMed Web of Science ®Google Scholar
• Genovese JA, Spadaccio C, Langer J, Habe J, Jackson J, Patel AN. Electrostimulation induces cardiomyocyte predifferentiation of fibroblasts. Biochem Biophys Res Commun 2008; 370: 450–5
   Google Scholar
• Genovese JA, Crespi MD, Castro G, Medina FH, Baldi A. Effects of human transforming growth factors on topoisomerases from normal fibroblasts. Life Sci 1988; 43: 2137–43
   Google Scholar
• Toma C, Pittenger MF, Cahill KS, Byrne BJ, Kessler PD. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 2002; 105: 93–8
   PubMed Web of Science ®Google Scholar
• Okamoto K, Miyoshi S, Toyoda M, Hida N, Ikegami Y, Makino H, et al. ‘Working’ cardiomyocytes exhibiting plateau action potentials from human placenta-derived extraembryonic mesodermal cells. Exp Cell Res 2007; 313: 2550–62
   PubMed Web of Science ®Google Scholar
• Rucker-Martin C, Pecker F, Godreau D, Hatem SN. Dedifferentiation of atrial myocytes during atrial fibrillation: role of fibroblast proliferation in vitro. Cardiovasc Res 2002; 55: 38–52
   PubMed Web of Science ®Google Scholar
• Cohn RD, Liang HY, Shetty R, Abraham T, Wagner KR. Myostatin does not regulate cardiac hypertrophy or fibrosis. Neuromuscul Disord 2007; 17: 290–6
   PubMed Web of Science ®Google Scholar
• Welt C, Sidis Y, Keutmann H, Schneyer A. Activins, inhibins, and follistatins: from endocrinology to signaling. A paradigm for the new millennium. Exp Biol Med (Maywood) 2002; 227: 724–52
   PubMedGoogle Scholar
• Amthor H, Nicholas G, McKinnell I, Kemp CF, Sharma M, Kambadur R, et al. Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis. Dev Biol 2004; 270: 19–30
   PubMed Web of Science ®Google Scholar
• Lee SJ, McPherron AC. Regulation of myostatin activity and muscle growth. Proc Natl Acad Sci USA 2001; 98: 9306–11
   PubMed Web of Science ®Google Scholar
• Wagner KR. Muscle regeneration through myostatin inhibition. Curr Opin Rheumatol 2005; 17: 720–4
   PubMed Web of Science ®Google Scholar
• Joulia D, Bernardi H, Garandel V, Rabenoelina F, Vernus B, Cabello G. Mechanisms involved in the inhibition of myoblast proliferation and differentiation by myostatin. Exp Cell Res 2003; 286: 263–75
   PubMed Web of Science ®Google Scholar
• Rios R, Carneiro I, Arce VM, Devesa J. Myostatin is an inhibitor of myogenic differentiation. Am J Physiol Cell Physiol 2002; 282: C993–9
   PubMed Web of Science ®Google Scholar
• Taylor WE, Bhasin S, Artaza J, Byhower F, Azam M, Willard DH, Jr, et al. Myostatin inhibits cell proliferation and protein synthesis in C2C12 muscle cells. Am J Physiol Endocrinol Metab 2001; 280: E221–8
   PubMed Web of Science ®Google Scholar
• Thomas M, Langley B, Berry C, Sharma M, Kirk S, Bass J, et al. Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem 2000; 275: 40235–43
   PubMed Web of Science ®Google Scholar
• Wagner KR, Liu X, Chang X, Allen RE. Muscle regeneration in the prolonged absence of myostatin. Proc Natl Acad Sci USA 2005; 102: 2519–24
   PubMed Web of Science ®Google Scholar
• Listrat A, Picard B, Geay Y. Age-related changes and location of type I, III, IV, V and VI collagens during development of four foetal skeletal muscles of double-muscled and normal bovine animals. Tissue Cell 1999; 31: 17–27
   PubMed Web of Science ®Google Scholar
• McPherron AC, Lee SJ. Suppression of body fat accumulation in myostatin-deficient mice. J Clin Invest 2002; 109: 595–601
   PubMed Web of Science ®Google Scholar
• McPherron AC, Lawler AM, Lee SJ. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997; 387: 83–90
   PubMed Web of Science ®Google Scholar
• Schuelke M, Wagner KR, Stolz LE, Hubner C, Riebel T, Komen W, et al. Myostatin mutation associated with gross muscle hypertrophy in a child. N Engl J Med 2004; 350: 2682–8
   PubMed Web of Science ®Google Scholar
• Wagner KR, McPherron AC, Winik N, Lee SJ. Loss of myostatin attenuates severity of muscular dystrophy in mdx mice. Ann Neurol 2002; 52: 832–6
   PubMed Web of Science ®Google Scholar